ATA Action Strengthens Digital Health Advocacy with Key Acquisition
Washington, DC, Monday, 5 May 2025.
ATA Action acquires Digital Therapeutics Alliance to bolster digital health innovation and policy efforts, signaling a major step in transforming patient care through enhanced technologies.
Strategic Integration for Digital Health Innovation
In a significant development announced on April 30, 2025, ATA Action has acquired the Digital Therapeutics Alliance (DTA), marking a strategic consolidation in the digital health advocacy space [1]. Under this arrangement, Andy Molnar, the current CEO of DTA and member of the FDA’s Digital Health Advisory Committee, will assume the role of head of digital health at ATA Action, while also serving as senior vice president of industry affairs at the ATA [1].
Expanding Advocacy and Policy Initiatives
The merger creates a powerful platform focused on removing barriers to telehealth access and ensuring continued regulatory momentum for digital therapeutics [1]. The newly formed organization will concentrate on crucial policy areas including expanded federal and state legislative resources for appropriate reimbursement, enhanced regulatory activity with FDA oversight, and improved access to evidence-based digital interventions [1]. This consolidation comes at a critical time, as the healthcare industry approaches significant policy changes, with key telehealth flexibilities set to expire on September 30, 2025 [2].
Future Implications for Digital Health
The acquisition has led to the formation of the Advancing Digital Health Coalition, which will focus on comprehensive digital health policy, encompassing digital therapeutics, Prescription Drug Use Related Software, Digital Mental Health Treatment Devices, and remote monitoring devices [1]. This integration aligns with broader industry trends, as demonstrated at the recent ATA Nexus 2025 conference, where industry leaders gathered to explore innovations in digital health delivery and regulatory frameworks [3][4].